NEW YORK (GenomeWeb) – PGXL Technologies today said that it has formed a partnership with NX PharmaGen under which the partners have created a research center focused on exosome analysis.
The PGXL NeXosome Center of Excellence will utilize NX PharmaGen's NeXosome microparticle enrichment technology to support identification of biomarkers. The partners said they will provide access to the platform and assay development services in a CLIA setting to researchers and biopharmaceutical firms.